Disease-specific pluripotent stem cells.
10.3345/kjp.2010.53.8.786
- Author:
Hoon Chul KANG
1
Author Information
1. Department of Pediatrics, Pediatric Epilepsy Clinics, Severance Children's Hospital, Epilepsy Research Institute, Yonsei University College of Medicine, Seoul, Korea. hipo0207@yuhs.ac
- Publication Type:Review
- Keywords:
Induced pluripotent stem cells;
Transcription factors
- MeSH:
Epigenomics;
Humans;
Induced Pluripotent Stem Cells;
Pluripotent Stem Cells;
Regenerative Medicine;
Transcription Factors
- From:Korean Journal of Pediatrics
2010;53(8):786-789
- CountryRepublic of Korea
- Language:English
-
Abstract:
Induced pluripotent stem (iPS) cells are generated by epigenetic reprogramming of somatic cells through the exogenous expression of transcription factors. Recently, the generation of iPS cells from patients with a variety of genetic diseases was found to likely have a major impact on regenerative medicine, because these cells self-renew indefinitely in culture while retaining the capacity to differentiate into any cell type in the body, thereby enabling disease investigation and drug development. This review focuses on the current state of iPS cell technology and discusses the potential applications of these cells for disease modeling; drug discovery; and eventually, cell replacement therapy.
